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Abstract
Background—The thickness of the cortical mantle is a sensitive measure for identifying
alterations in cortical structure. We aimed to explore whether first episode schizophrenia patients
already show a significant cortical thinning and whether cortical thickness anomalies may
significantly influence clinical and cognitive features.
Method—We investigated regional changes in cortical thickness in a large and heterogeneous
sample of schizophrenia spectrum patients (n=142) at their first break of the illness and healthy
controls (n=83). Magnetic resonance imaging brain scans (1.5 T) were obtained and images were
analyzed by using BRAINS2. The contribution of sociodemographic, cognitive and clinical
characterictics was investigated.
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Results—Patients showed a significant total cortical thinning (F=17.55, d=−0.62, p<0.001) and
there was a diffuse pattern of reduced thickness (encompassing frontal, temporal and parietal
cortices) (all p’s<0.001, d’s>0.53). No significant group × gender interactions were observed (all
p’s>0.15). There were no significant associations between the clinical and pre-morbid variables
and cortical thickness measurements (all r’s<0.12). A weak significant negative correlation
between attention and total (r=−0.24, p=0.021) and parietal cortical thickness (r=−0.27, p=0.009)
was found in patients (thicker cortex was associated with lower attention). Our data revealed a
similar pattern of cortical thickness changes related to age in patients and controls.
Conclusions—Cortical thinning is independent of gender, age, age of onset and duration of the
illness and does not seem to significantly influence clinical and functional symptomatology. These
findings support a primary neuro-development disorder affecting the normal cerebral cortex
development in schizophrenia.
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Introduction
Imaging and neuropathological evidence indicates that schizophrenia is associated with
cortical structural abnormalities. Cortical thickness and surface area offer important
information about brain development processes (Rockel et al. 1980; Bystron et al. 2008) and
cortical structure (Kruggel et al. 2003; Sowell et al. 2003). In schizophrenia, regional gray-
matter thinning in frontal, temporal and parietal heteromodal association cortices (White et
al. 2003; Narr et al. 2005a,b; Venkatasubramanian et al. 2008) and a differential pattern of
cortical thickness asymmetry (Haller et al. 2009) have been reported in first episode
patients. Marked global and regional (frontal and temporal) thickness reductions have also
been observed in chronic samples (Kuperberg et al. 2003; Nesvag et al. 2008; Goldman et
al. 2009). A different pattern of cortical thickness abnormalities in sulci and gyri has also
been associated with the illness. Cortical thickness anomalies are more prominent in the
sulci than in the gyri (White et al. 2003; Goghari et al. 2007). The differential effects of age,
gender, diagnoses, handedness and antipsychotic medication on variation in cortical
thickness in schizophrenia have also been explored with inconclusive findings (Narr et al.
2005a).
It is of interest that variability in cortical thickness has been associated with differences in
general intelligence (Gong et al. 2005; Shaw et al. 2006) and cognitive abilities (Karama et
al. 2009). In this line of research, reduced cortical thickness is associated with deficits in a
wide variety of cognitive functions in rats (Flagstad et al. 2005). We hypothesized that
neuropsychological deficits in schizophrenia could be linked with the observed pattern of
brain changes affecting frontal, temporal and parietal heteromodal association cortices.
However, only a few studies have assessed the behavioral significance of morphometric
cortical anomalies in first episode schizophrenia (for a review, see Crespo-Facorro et al.
2007). The present investigation might shed additional light into the field.
It is yet to be elucidated whether: (1) these cortical anomalies in first episode schizophrenia
could be related, at least in part, to the effect of the illness itself, gender, age or handedness;
(2) these cortical anomalies may significantly influence clinical and cognitive features of the
illness.
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Method
Study setting and financial support
Data for the present investigation were obtained from a large epidemiological and 3-year
longitudinal intervention programme of first-episode psychosis (PAFIP) conducted at the
out-patient clinic and the in-patient unit at the University Hospital Marques de Valdecilla,
Santander, Spain. It conformed to international standards for research ethics and was
approved by the local institutional review board. A more detailed description of our
programme has been previously reported (Pelayo-Terán et al. 2008).
Subjects
From February 2001 to December 2007 all referrals to PAFIP were screened for patients
who met the following criteria : (1) age 15–60 years; (2) living in the catchment area; (3)
experiencing their first episode of psychosis; (4) no prior treatment with antipsychotic
medication or, if previously treated, a total life-time of adequate antipsychotic treatment <6
weeks; (5) meeting DSM-IV criteria for schizophrenia, schizophreniform disorder, brief
psychotic disorder, or schizoaffective disorder. Patients were excluded for any of the
following reasons: (1) meeting DSM-IV criteria for drug dependence (except nicotine
dependence); (2) meeting DSM-IV criteria for mental retardation ; (3) having a history of
neurological disease or head injury. The diagnoses were confirmed using the Structured
Clinical Interview for DSM-IV (First et al. 2001) carried out by an experienced psychiatrist
6 months from the baseline visit.
A total of 264 first episode patients who were included in PAFIP were invited to undergo a
magnetic resonance imaging (MRI) scan. Of those 264 patients, 89 individuals refused to
participate, 23 individuals were unable to complete the scan and 10 obtained poor quality
images. Therefore, a final set of 142 patients with a high quality baseline MRI scan were
analyzed in this study. No differences in main socio-demographic and clinical characteristics
were found when patients with and without MRI were compared (data not shown).
At 6 months after enrolment in the study, their Axis I diagnoses were schizophrenia (n=82,
57.7%), schizophreniform disorder (n=36, 25.4%), schizoaffective disorder (n=3, 2.1%),
brief psychotic disorder (n=13, 9.2%) and not otherwise specified psychosis (n=8, 5.6%).
A group of 83 healthy volunteers were initially recruited from the community through
advertisements. They had no current or past history of mental retardation or of psychiatric,
neurological or general medical illnesses, including substance abuse and significant loss of
consciousness, as determined by using an abbreviated version of the Comprehensive
Assessment of Symptoms and History (Andreasen et al. 1992). The absence of psychosis in
first-degree relatives was also confirmed by clinical records and family interview. After a
detailed description of the study, each subject gave written informed consent to participate,
in accordance with local ethics committee.
Clinical and cognitive assessments
Clinical symptoms were rated using the Brief Psychiatric Rating Scale total (Overall &
Gorman, 1962), the Scale for the Assessment of Negative Symptoms (Andreasen, 1983) and
the Scale for the Assessment of Positive Symptoms (Andreasen, 1984). We also divided
psychopathology into three dimensions of symptoms (psychotic, negative and disorganized).
All study subjects were invited to complete a comprehensive cognitive battery (Gonzalez-
Blanch et al. 2007). For this investigation, we selected six cognitive tests that comprise five
cognitive domains, with outcome measures shown in parentheses: (1) executive functions :
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Trail Making Test B (time to complete); (2) working memory: Wechsler Adult Intelligence
Scale (WAIS) III – backward digits (total score) ; (3) speed of processing: WAIS III-Digit
Symbol (standard total score) ; (4) attention : Continuous Performance Test (CPT)
Degraded-Stimulus (total number of correct responses); (5) visual memory: Rey Complex
Figure Test (long-term recall measure). The WAIS III subtest of vocabulary (number of
words generated) was used as pre-morbid IQ. Handedness was assessed by the Edinburgh
Inventory (Oldfield, 1971).
Medication assessment
Patients went through a pharmacological protocol and were randomly assigned to treatment
with risperidone (n=24, 16.9%), olanzapine (n=24, 16.9%), quetiapine (n=25, 17.6%),
ziprasidone (n=26, 18.3%), aripiprazole (n=21, 14.8%) or haloperidol (n=22, 15.5%). Only
three patients had been minimally treated prior to randomizing to antipsychotic treatments.
Patients had a baseline structural MRI as soon as they could tolerate the procedure following
the initiation of treatment. The mean time between initiation of antipsychotic treatment and
baseline MRI scan was 4.42 weeks (range 0.14–18.57).
MRI acquisition and image processing
All multi-modal MRI scans were obtained at the University Hospital of Cantabria using a
1.5 Tesla General Electric SIGNA System (GE Medical Systems, USA). Three-dimensional
T1-weighted images, using a spoiled grass sequence were acquired in the coronal plane (see
Crespo-Facorro et al. 2007 for details).
Processing of the images was done by using BRAINS2 (Andreasen et al. 1996; Magnotta et
al. 2002). The T1 scan was loaded and resample to 1.0 mm3. The definition of Talairach
parameters was accomplished to define how the Talairach grid is warped on to the brain.
The T2 and proton density (PD) datasets were aligned to the resampled T1 image. The co-
registered T1, T2 and PD image sets were used as input into a tissue classification module,
which can handle multispectral data (Harris et al. 1999). The segmented image is used to
extract a triangle-based polygonal model of an iso-surface, representing the parametric
center of the gray-matter tissue class (Magnotta et al. 1999). The resulting three-dimensional
iso-surface approximates the spatial center of the cortex and is used to provide estimates of
values that are direct or indirect quantitative measurements of cerebral cortex.
Measurements
Cortical depth—This measure is the minimum distance between the 100% gray-matter
triangle surface and the 50%/50% gray/white matter surface. This measure is an index of
cortical thickness ; it represents the parametric center of the cortex or approximately one-
half the cortical thickness.
Cortical surface area—This value is the sum of the areas of the triangles making up the
surface of the brain.
The methods used to quantify these aspects of surface anatomy have been extensively
evaluated and validated (Magnotta et al. 1999).
Statistical analysis
All statistical analyses were performed with the SPSS software version 15 (SPSS Inc.,
USA). Because of the skewed distribution of duration of untreated psychosis (DUP),
duration of untreated illness (DUI) and age of onset, a logarithmic transformation was
conducted to convert data to normal distribution.
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To examine differences in morphological measurements between patients and healthy
subjects, a repeated-measures analysis of covariance (ANCOVA) was performed.
For the primary analysis, the between subject factors were group (patients and controls) and
gender, and the within subject factor (repeated measures) was side (left or right). Cortical
thickness and surface area were used as the dependent variables. Age was used as
covariates. The group by side interaction was used to determine differences in asymmetry
between groups. All post-hoc comparisons were Bonferroni corrected.
As a secondary analysis, we explored the specificity of these cortical anomalies between the
different diagnostic groups using as the between subject factor the three diagnostic groups:
schizophrenia; schizophreniform; non-schizophrenic non-affective (NSNA) psychosis.
We also analyzed all the morphological measurements in the sample using only right-
handed individuals to rule out the effect of handedness.
Cohen’s d is provided to estimate the magnitude of the differences between groups. A two-
tailed α-level of 0.05 was used for statistical testing.
Pearson correlation coefficients were used as an explanatory analysis to assess the
relationship between morphological measurements and cognitive and clinical variables. In
this correlation analysis, we used a more stringent threshold (p<0.01) of statistical
significance to dismiss spurious statistically significant claims. Once we identified the
variables that were more likely related with cortical thickness, we carried out a multiple
regression analysis in order to discriminate the factors that more accurately predict cortical
thickness in our sample. As independent variables, we included not only the significant
variables from the correlational analysis but also variables that could be potentially
confounding factors : gender, age, cannabis consumption and years of education.
Results
Subject characteristics
The comparisons of patients and controls regarding sociodemographic, clinical and
cognitive characteristics are presented in Table 1. All were Caucasian. There were no
significant differences between patients and controls with regard to age, gender, height,
educational level, parental socio-economic status and alcohol or cannabis consumption.
When the three diagnostic groups of patients (schizophrenia, schizophreniform and NSNA
psychosis) were statistically explored, there were no statistically significant differences in
relevant sociodemographic characteristics between the three groups of patients and controls
(data are available from the first author upon request).
Global cortical measurements
Table 2 displays the results from the analysis evaluating each cortical measure in patients
and healthy subjects. The total intracranial brain volume did not differ between groups (see
Table 1).
For total cortical thickness, the two groups showed significant differences with a medium-
large effect size (F=13.54, d=−0.62, p<0.001). When specific measures of sulcal and gyral
thickness were evaluated, both measures differed between the groups (F=27.48, d=−0.81,
p<0.001 and F=6.55, d=−0.47, p=0.011, respectively). Those subjects with psychosis had
significantly thinner total, gyri and sulci cortical thickness. Results remained similar after
adjusting for age and intracranial volumen.
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There were no significant differences between the two groups in cortical surface area
(F=0.82, d=0.05, p=0.365).
There were no significant differences between the diagnostic groups in cortical thickness
and cortical surface area (all p’s>0.132) (data are presented in the supplementary material).
Regional cortical measurements
The cortical measurements were also evaluated for each of the four cerebral lobes (Table 2).
The pattern of regional cortical thickness in patients compared with healthy controls
revealed a higher significant thinning in frontal, temporal, parietal and occipital cortices (all
p’s<0.037, d’s< −0.38). The marked sulcal thinning extended to all cerebral lobes (all p’s<0.
001, d’s< −0.58), whereas gyral thinning was localized in frontal and temporal regions
(F=5.18, d=−0.44, p=0.024, F=10.10, d = −0.53, p=0.002, respectively). No regional
differences in cortical surface area were observed.
Intervening variables
We also examined whether these cortical anomalies were mediated by the differential
influence of gender, age and handedness.
Factor scores from the ANCOVA did not show main effects of group by gender for any of
the cortical thickness variables (all p’s > 0.114) (see Table 2). Similarly, no significant
group × side interactions were noted for any of the cortical measures.
Significant correlations were found between cortical thickness and age in the two groups,
schizophrenia (r = −0. 514; p < 0.0001) and young healthy volunteers (r = −0. 408; p <
0.0001). These correlations suggest that the younger the individual, the thicker the cortical
ribbon. Correlations between cortical thickness and age were performed within each gender
(see Fig. 1). The analysis of the slopes of the correlations revealed no significant differences
in the effect of age in males, patients and controls (r=−0.373 and r=−0.315, respectively).
Similarly, female patients and female controls showed a comparable effect of age on cortical
thickness (r=−0.721 and r=−0.613, respectively). Decrease in mean cortical thickness with
increasing age in the four cerebral lobes was similar in patients and controls (data not
shown).
Finally, the analysis of only right-handed individuals (n=125 patients and n=75 controls)
revealed a similar significant group effect for cortical thickness and similar lack of
significant group by side interactions than when we analyzed the complete sample.
Handedness does not seem to affect significantly cortical thickness anomalies found in first
episode schizophrenia.
All these analyses of correlation are available from the first author upon request.
Correlations between cortical thickness and clinical and cognitive measures
Correlations between clinical symptoms and cortical thickness measures are shown in Table
3. There were no significant associations between the severity of symptoms at baseline and
any of the cortical thickness (all |r’s| <0.12 and p’s>0.15). No significant associations were
seen either between DUP, DUI, duration of prodromic period (DPP) and age of onset and
cortical thickness measurements (all |r’s| <0.12 and p’s>0.15).
Correlations between cortical and cognitive measurements are shown in Table 4. Patients
had a weak significant negative correlation between attention and total and parietal cortical
thickness (r= −0.24, p=0.021 and r=−0.27, p=0.009, respectively). Only the latter
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association remains statistically significant when using a more stringent threshold (p<0.01).
No other significant associations between cognitive variables and cortical measurements
were found.
Based on the previous correlation analysis, CPT scores, age, gender, years of education and
cannabis use were entered in a stepwise linear regression model. The final model predicts a
part of the variability of parietal cortical thickness (F=18.02, p<0.001; R2= 0.275).
Univariate analysis shows that age (β: −0.507; p<0.001), and CPT scores (β=−0.211,
p=0.018) were significantly associated with parietal cortical thickness.
Discussion
We found that patients with schizophrenia at the first break of the illness already showed a
significant cortical thinning compared with young healthy volunteers. There was a diffuse
pattern of reduced thickness (encompassing frontal, temporal and parietal heteromodal
association cortices) and a marked thinning of sulci. These morphological changes seem to
be independent of age, gender, handedness and other intervening variables. Cortical thinning
in schizophrenia does not seem to significantly influence clinical and functional
symptomatology. Interestingly, the three diagnostic groups of patients show a similar pattern
of cortical thickness, suggesting a common neurobiological pattern that might be shared by
non-affective psychotic illness.
Cortical thickness and surface area
Although not all studies have found consistent results (Wiegand et al. 2004; Haller et al.
2009), a significant cortical thinning has been observed in first episode schizophrenia with a
childhood and adolescent (White et al. 2003) and adult (Narr et al. 2005a, b;
Venkatasubramanian et al. 2008) onset. These studies suggested that cortical regions most
affected may be frontal, temporal and parietal heteromodal association cortices. In addition
to frontopolar and cingulate thickness reductions, Narr and colleagues (2005b) observed
cortical thinning within the occipital cortex. Venkatasubramanian and colleagues (2008)
described that prefrontal thickness deficits seem to be significantly located in the medial
orbitofrontal cortices. The small sample size in the negative studies from Wiegand et al.
(2004) and Haller et al. (2009) (n=17 and n=20, respectively) may explain the inconsistency
of their results. In chronic schizophrenia, widespread cortical thinning with a distinct
reduction in temporal and frontal thickness (Kuperberg et al. 2003; Nesvag et al. 2008;
Goldman et al. 2009) and parietal operculum sulcal thinning (Csernansky et al. 2008) has
been also observed. Due to the demonstrated differential maturation trajectories of the
cortical regions (Gogtay et al. 2004), insults disrupting later stages of cortical maturation
might distinctly affect anterior cortical regions with a lesser impact on posterior cortical
regions (Nesvag et al. 2008). It may be hypothesized that cellular shrinkage, reduction in
dendritric arborization and disruptions in white matter bundles connecting association
cortical areas are pathological mechanisms that account for cortical thinning and impaired
connectivity and functionality (Morrison & Hof, 1997; Rajkowska, 1997; Selemon et al.
1998). The precise description of the relationship between neuropathological abnormalities
and the reduction of cortical thickness in schizophrenia is still obscure.
Our finding of a reduction of 5.5% in total cortical thickness is consistent with the results of
a previous study on early onset schizophrenia using a similar methodological approach
(White et al. 2003). Venkatasubramanian and colleagues (2008) also reported a 5.1%
thickness reduction in orbitofrontal cortex. The cortical thinning found in chronic patients
seems to be of a similar or even lesser magnitude than in first episode patients (Kuperberg et
al. 2003; Nesvag et al. 2008). We hypothesized that cortical thinning found in early stages
of the illness is stable and relatively independent of the course of the illness itself.
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Previous imaging studies in schizophrenia have shown a differential cortical thickness
asymmetry (Hamilton et al. 2007). Haller and colleagues (2009) observed that cortical
thickness asymmetries but not direct cortical thickness measurements may be distinctively
affected in first episode patients. We found herein that both healthy volunteers and first
episode patients have a similar pattern of cortical asymmetries (see Table 2).
Differences in structure and connectivity exist between gyri and sulci (Hilgetag & Barbas,
2006) and thicker gyral crowns have been described in healthy controls (White et al. 2003).
We have consistently demonstrated differences in total cortical thickness of gyri and sulci
[4.58 (0.50) mm and 3.74 (0.37) mm, respectively] in healthy volunteers (Crespo-Facorro et
al. in press). We found herein a widespread and prominent thinning of cortical thickness of
sulci. Similar results have also been found in childhood and adolescent schizophrenia
compared with healthy volunteers (White et al. 2003). Goghari and colleagues (2007) have
suggested that sulcal thinning in the superior temporal and cingulate regions may serve as
structural endophenotype in schizophrenia.
No lobar or global anomalies in surface area were observed in the present study. In first
episode schizophrenia patients, reductions in specific cortical surface area (orbitofrontal,
straight gyrus and insular cortex) have been described (Crespo-Facorro et al. 2000a, b).
Wiegand and colleagues (2004) did not find significant differences in prefrontal complexity
measure (an estimate of cortical surface area) in first episode patients compared with healthy
volunteers. We might conclude that during the early phases of schizophrenia there is no
evidence of a cortical surface reduction either globally or in lobes, although anomalies in
more specific cortical subregions might be present.
Intervening variables
We found a significant effect of age in cortical thickness. However, our data revealed a
similar pattern of cortical thickness changes related to age in both groups. In healthy
volunteers, males seem to have more pronounced age-related cortical thinning (Good et al.
2001) and cortical atrophy (Coffey et al. 1998) than females. In schizophrenia, whole brain
gray-matter volumes and regional changes in intensity-based gray-matter concentration were
shown to occur prematurely in male patients with chronic schizophrenia (Narr et al. 2003).
Nesvag and colleagues (2008) described differences in the aged-related thickness changes in
chronic patients and controls. However, the existence of a distinctive pattern of age-related
cortical thickness changes in schizophrenia is still under debate (Weinberger & McClure,
2002). The present study showed no significant effect of schizophrenia in age-related
cortical thickness variations. Moreover, we did not find any difference between patients and
controls in age-related cortical thickness when males and females were compared
independently (see Fig. 1).
We observed that in schizophrenia there is not a significant influence of gender in cortical
thickness and surface area. Narr et al. (2005b) observed no significant gender differences in
cortical thickness across the entire cortex in patients with a first episode of schizophrenia.
Differential cortical thickness asymmetries in schizophrenia have been associated with
handedness (Hamilton et al. 2007). Although there was no difference in handedness between
our groups, we have further investigated the influence of handedness in asymmetries of
cortical measures by analyzing only the subsample of right-handed individuals. No
significant effects in global or regional cortical measures were associated with handedness.
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Clinical and cognitive correlations
No evidence of a significant association between age of onset, DUP, DUI and DPP and
cortical measurements was found (Table 3). Some of the previous studies, but not all
(Wiegand et al. 2004), have also failed to demonstrate significant associations between
clinical pre-morbid variables and cortical thickness in schizophrenia (Kuperberg et al. 2003;
Nesvag et al. 2008). In addition, there were no significant associations between clinical
features (total scores of the three dimensions) and cortical measurements. Although a small
negative correlation between the severity of negative symptomatology and the thickness of
left medial orbitofrontal cortex has been observed (Venkatasubramanian et al. 2008), most
of the previous studies did not consistently find significant correlations between cortical
thickness values and psychopathological variables (Kuperberg et al. 2003; Wiegand et al.
2004; Goldman et al. 2009). Wiegand et al. (2004) have described that patients who were
younger at the time of their first episode have a significant thicker prefrontal cortex,
suggesting a relationship between age of onset and cortical thickness in schizophrenia. We
did not find any association between the age of onset of the illness and cortical
measurements.
We found a significant association between attention and parietal thickness in schizophrenia
patients. Previous functional and morphometric imaging studies have shown that deficits in
attention were related to abnormalities of the parietal cortex in schizophrenia (Salgado-
Pineda et al. 2003, 2004; Weiss et al. 2007). Gender did not influence the pattern of
correlations between cognitive functioning and cortical thickness in patients. Our group has
recently observed significant correlations between cognitive functioning and prefrontal and
parietal thickness in healthy females, but not in healthy males (Crespo-Facorro et al. in
press). However, despite this differential pattern of associations between cognition and
cortical measurements in patients and controls, no significant differences in semantic
memory and executive functioning were found between female patients and controls.
Methodological limitations
There were a few limitations to this study. First, because of the distribution of ages in our
sample it was not possible to correctly explore the effect of age in cortical measures.
Although a wide range of ages have been included (age ranged from 17.23 to 57.88 years),
75% of the total sample was younger than 33.8 years. Second, although our patients were
minimally treated (mean=4.42 weeks) the effect of antipsychotic medication in cortical
thickness should not be ruled out. Previous investigations did not report the influence of
antipsychotic medications in cortical thickness (Kuperberg et al. 2003; Narr et al. 2005a, b).
Longitudinal studies are warranted to determine changes in the cerebral surface anatomy
during the course of the illness and also to determine the effects of different antipsychotic
treatments. Finally, it was not possible from our findings to explore the possibility that
group differences also exist on a finer microstructural level, including cellular architecture
and connectivity.
Conclusions
In the present study, we observed spread differences in cortical thickness between first
episode schizophrenia patients and healthy volunteers. The fact that cortical thinning is
already present at early phases of the illness and is independent of intervening variables
offers evidence for the potential of these changes to be a biological marker of the illness and,
in turn, their value as neurodevelopmental endophenotypes should be evaluated. Further
studies are warranted to elucidate the influence of different neurobiological mechanisms
(cellular shrinkage, reduction in dendritric arborization and disruptions in white matter
bundles) associated with reduced cortical thickness in schizophrenia.
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Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
Correlations between total cortical thickness and age in patients and healthy volunteers.
Crespo-Facorro et al. Page 14
Psychol Med. Author manuscript; available in PMC 2014 March 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Crespo-Facorro et al. Page 15
Table 1
Demographic and clinical characteristics of patients and healthy volunteers
Patients (n=142) Controls (n=83) Statistics
Males n, (%) 88 (61.97) 52 (62.65) χ2=0.01, p=0.92
Age at MRI, mean, (S.D.), years 29.73 (8.70) 27.57 (7.57) F=3.55, p=0.06
Height, mean (S.D.), cm 169.04 (9.33) 171.29 (8.70) F=3.15, p=0.08
Right-handed n, (%)a 125 (89.93) 75 (91.46) χ2=0.14, p=0.71
Age at onset, mean, (S.D.), years 28.55 (8.35) – –
Intracranial volume, mean (S.D.), ml 1377.34 (136.96) 1384.83 (124.81) F=0.17, p=0.68
Parental socio-economic status, mean (S.D.)b,e 3.64 (0.91) 3.51 (0.75) F=1.12, p=0.29
Low academic level n, (%)f 72 (50.70) 32 (39.51) F=2.60, p=0.11
Alcohol users n, (%)c 88 (62.97) 50 (63.29) F=0.04, p=0.85
Cannabis users n, (%)c 69 (48.59) 30 (37.50) F=2.55, p=0.11
Tobacco users n, (%)c 81 (57.04) 47 (58.75) F=0.06, p=0.81
DUP mean, (S.D.), median, months 12.48 (28.84), 3.00 – –
DUI mean, (S.D.), median, monthsd 28.61 (48.16), 12.00 – –
DPP mean, (S.D.) median, monthsd 16.06 (37.51), 4.00 – –
Symptomatology (total scores)
 SANS 6.31 (5.12) – –
 SAPS 13.63 (4.33) – –
 Psychotic dimension 7.46 (2.34) – –
 Disorganized dimension 6.17 (3.41) – –
 Negative dimension 4.46 (4.85) – –
MRI, Magnetic resonance imaging; DPP, duration of prodromic period [period from the first unspecific symptoms related to psychosis to the first
continuous (present most of the time) psychotic symptom]; DUI, duration of untreated illness [time from the first unspecific symptoms related to
psychosis (for such a symptom to be considered, there should be no return to the previous stable level of functioning) to initiation of adequate
antipsychotic drug treatment] ; DUP, duration of untreated psychosis [time from the first continuous (present most of the time) psychotic symptom
to initiation of adequate antipsychotic drug treatment] ; SANS, Scale for the Assessment of Negative Symptoms; SAPS, Scale for the Assessment
of Positive Symptoms.
a
Based on data from 139 patients and 82 volunteers.
b
Based on data from 141 patients and 80 volunteers.
c
Based on data from 142 patients and 80 volunteers.
d
Based on data from 141 patients.
e
Parental socio-economic status is based on the Hollingshead–Redlich scale.
f
Low academic level was defined as secondary education or lower.
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